Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis

Review (54 RCTs; n=9612) found oral 5‐aminosalicylic acid (5‐ASA) superior to placebo, but not more effective vs sulfasalazine. Once daily dosing of 5‐ASA is as efficacious as conventional dosing and little difference in efficacy/safety among various 5‐ASA formulations.

Source:

Cochrane Database of Systematic Reviews